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Abstract. 
 
The speciﬁc localization of L-type Ca
 
2
 
1
 
 chan-
nels in skeletal muscle triads is critical for their normal
function in excitation–contraction (EC) coupling. Re-
constitution of dysgenic myotubes with the skeletal
 
muscle Ca
 
2
 
1
 
 channel 
 
a
 
1S
 
 subunit restores Ca
 
2
 
1
 
 currents,
EC coupling, and the normal localization of 
 
a
 
1S
 
 in the
triads. In contrast, expression of the neuronal 
 
a
 
1A
 
 sub-
unit gives rise to robust Ca
 
2
 
1
 
 currents but not to triad
localization. To identify regions in the primary structure
of 
 
a
 
1S
 
 involved in the targeting of the Ca
 
2
 
1
 
 channel into
the triads, chimeras of 
 
a
 
1S
 
 and 
 
a
 
1A
 
 were constructed,
expressed in dysgenic myotubes, and their subcellular
distribution was analyzed with double immunoﬂuores-
cence labeling of the 
 
a
 
1S
 
/
 
a
 
1A
 
 chimeras and the ryano-
dine receptor. Whereas chimeras containing the COOH
terminus of 
 
a
 
1A
 
 were not incorporated into triads, chi-
meras containing the COOH terminus of 
 
a
 
1S
 
 were cor-
rectly targeted. Mapping of the COOH terminus re-
vealed a triad-targeting signal contained in the 55
amino-acid sequence (1607–1661) proximal to the puta-
tive clipping site of 
 
a
 
1S
 
. Transferring this triad targeting
signal to 
 
a
 
1A
 
 was sufﬁcient for targeting and clustering
the neuronal isoform into skeletal muscle triads and
caused a marked restoration of Ca
 
2
 
1
 
-dependent EC
coupling.
Key words: calcium channel • dihydropyridine recep-
tor • excitation–contraction coupling • immunoﬂuores-
cence • skeletal muscle
 
Introduction
 
The precise localization of Ca
 
2
 
1
 
 channels in specialized
membrane domains is essential for their specific actions in
multiple functions of excitable cells. In neurons, for exam-
ple, voltage-gated Ca
 
2
 
1
 
 channels located in the nerve ter-
minal trigger neurotransmitter release and distinct popula-
tions of pre- and postsynaptic Ca
 
2
 
1
 
 channels participate in
different forms of synaptic plasticity (Berridge, 1998). In
muscle cells, voltage-gated Ca
 
2
 
1
 
 channels are specifically
located in the intracellular junctions between the Ca
 
2
 
1
 
stores of the sarcoplasmic reticulum (SR)
 
1
 
 and either the
transverse tubules (t tubules) or the plasma membrane,
called triads and peripheral couplings, respectively (Fran-
zini-Armstrong and Jorgenson, 1994), in which the Ca
 
2
 
1
 
channel initiates excitation–contraction (EC) coupling
(Melzer et al., 1995). Even though voltage-gated Ca
 
2
 
1
 
channels play such important roles in vital cell functions,
the signals and mechanisms that direct and immobilize the
different voltage-gated Ca
 
2
 
1
 
 channel isoforms into their
specific membrane domains are not known.
The skeletal muscle L-type Ca
 
2
 
1
 
 channel (also called di-
hydropyridine receptor, DHPR) is composed of four sub-
units, the pore-forming 
 
a
 
1S
 
 and the accessory 
 
a
 
2
 
/
 
d
 
, 
 
b
 
1a
 
, and
 
g
 
1
 
 subunits (Catterall, 1996). The channel is concentrated
in the junctional membranes of the triads (Jorgensen, 1989;
Flucher et al., 1990), where it is in close contact with the
Ca
 
2
 
1
 
 release channels (ryanodine receptors, RyR) of the
SR Ca
 
2
 
1
 
 stores. Freeze-fracture analysis showed that in
the triad junctions the DHPRs are arranged in square
groups of four integral membrane particles called the tet-
rads and that their distribution pattern corresponds to that
of the RyR arrays in the opposite SR membrane (Block et
al., 1988). It is believed that the skeletal muscle DHPR
functions as the voltage sensor for the gating of the SR Ca
 
2
 
1
 
release channel by a mechanism that is independent of Ca
 
2
 
1
 
influx through the L-type channel (Ríos et al., 1992). Thus,
the highly orderly arrangement of DHPRs and RyRs in the
triads is the structural basis for the depolarization-induced
SR Ca
 
2
 
1
 
 release in skeletal muscle EC coupling.
But what are the mechanisms by which the Ca
 
2
 
1
 
 chan-
nels are specifically targeted into the triad junction and by
which they achieve their characteristic organization? In
skeletal muscle of the dysgenic mouse, which lacks the 
 
a
 
1
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subunit of skeletal muscle DHPR, triads form and RyRs
are normally incorporated in these junctions in the ab-
sence of 
 
a
 
1S
 
 (Powell et al., 1996). Conversely, in myotubes
of a skeletal RyR knock-out mouse, triads are also formed
and DHPRs aggregate in these junctions, despite the ab-
sence of the RyR (Takekura et al., 1995); however, their
arrangement in tetrads fails (Protasi et al., 1998). This sug-
gests that triad targeting and tetrad formation are two in-
dependent processes and that interactions with the RyR
are not necessary for the targeting of the DHPR into the
junctional membrane domain of the triad. Evidence from
studies in heterologous expression systems showing that
coexpression of the DHPR 
 
a
 
1
 
 subunit with 
 
b
 
 and 
 
a
 
2
 
/
 
d
 
 in-
creases membrane insertion of functional Ca
 
2
 
1
 
 channels
(Chien et al., 1995; Brice et al., 1997; Neuhuber et al.,
1998a; Walker et al., 1998) suggests a role of the accessory
Ca
 
2
 
1
 
 channel subunits in the targeting process. Moreover,
Ca
 
2
 
1
 
 currents and EC coupling are deficient in skeletal
myotubes of 
 
b
 
-null mice and both functions can be recon-
stituted by heterologous expression of 
 
b
 
1a
 
 (Gregg et al.,
1996; Beurg et al., 1997). Thus, expression of the 
 
b
 
 subunit
is important for the efficient expression and functional in-
sertion of the Ca
 
2
 
1
 
 channel in the membrane, but not nec-
essarily for its targeting into triads. Immunolocalization of
 
a
 
2
 
/
 
d
 
 and of recombinant 
 
b
 
1a
 
 
 
expressed in dysgenic myo-
tubes showed that, without the 
 
a
 
1S
 
 subunit, both subunits
failed to be localized in the junctions (Flucher et al., 1991;
Neuhuber et al., 1998b). Instead, the 
 
b
 
 and 
 
a
 
2
 
/
 
d
 
 subunits
required coexpression of 
 
a
 
1S
 
 for their own incorporation
into the triads, suggesting that their own triad targeting is
secondary to that of the 
 
a
 
1S
 
 subunit and that 
 
b
 
 and 
 
a
 
2
 
/
 
d
 
 do
not posses an independent targeting signal. The role of the
 
g
 
 subunit of the skeletal muscle Ca
 
2
 
1
 
 channel is still poorly
understood. However, the fact that EC coupling is not per-
turbed in skeletal muscle of a 
 
g
 
 knock-out mouse also sug-
gests that this subunit is not required for a function as im-
portant as the targeting of the Ca
 
2
 
1
 
 channel complex into
the triad (Freise et al., 2000). Thus, considering that the
RyR and the accessory DHPR subunits either play no role
in triad targeting of the DHPR or depend on the 
 
a
 
1S
 
 sub-
unit for their own targeting into the junctions, the signal
for triad targeting is likely to be contained within the 
 
a
 
1S
 
subunit itself.
Here, we used heterologous expression of different 
 
a
 
1
 
subunit isoforms and isoform chimeras in dysgenic myo-
tubes to identify the targeting signal in the skeletal muscle
DHPR. Taking advantage of differential targeting proper-
ties of the skeletal muscle 
 
a
 
1S
 
 and the neuronal 
 
a
 
1A
 
 sub-
unit, we generated a series of 
 
a
 
1S
 
/
 
a
 
1A
 
 chimeras and used
them to localize the triad targeting signal in the COOH
terminus of 
 
a
 
1S
 
. The 55 amino acid sequence of 
 
a
 
1S
 
, which
is sufficient to confer triad targeting properties to 
 
a
 
1A
 
, is
the first description of a targeting signal of a voltage-gated
Ca
 
2
 
1
 
 channel to its native membrane domain.
 
Materials and Methods
 
Cell Culture and Transfections
 
Myotubes of the homozygous dysgenic (
 
mdg/mdg
 
) cell line GLT were cul-
tured as described in Powell et al. (1996). At the onset of myoblast fusion
(2–4 d after addition of differentiation medium), GLT cultures were trans-
fected using DOTAP or FuGene (Boehringer). Cultures were analyzed
3–4 d after transfection.
 
Construction of Chimeric 
 
a
 
1
 
 Subunits
 
The cDNA coding sequences of Ca
 
2
 
1
 
 channel 
 
a
 
1S
 
/
 
a
 
1A
 
 subunit chimeras were
inserted in-frame 3
 
9
 
 to the coding region of a green fluorescent protein
(GFP), which was modified for thermal stability (Grabner et al., 1998) and
contained in a proprietary mammalian expression vector (kindly provided by
P. Seeburg, Zentrum für Molekulare Biologie, Heidelberg, Germany). Inser-
tion of the cDNAs was accomplished as follows (nucleotide numbers, nt, are
given in parentheses; asterisks indicate restriction sites introduced by PCR).
 
GFP-
 
a
 
1S
 
, GFP-
 
a
 
1A
 
. 
 
Construction of the GFP-tagged 
 
a
 
1S 
 
(Tanabe et al.,
1987) and 
 
a
 
1A
 
 (Mori et al., 1991) subunits that were used as maternal
clones for chimerization are described elsewhere (Grabner et al., 1998).
 
GFP-
 
a
 
1
 
SkNa.  
 
The 
 
a
 
1A 
 
(A) cDNA coding for the NH
 
2
 
 terminus
 
 
 
was
fused to the 
 
a1S (Sk) cDNA at position (nt A294/Sk154) using the “gene
SOEing” technique (Horton et al., 1989). The SalI*-SacI fragment (nt 59
polylinker-Sk651) of the cDNA product generated by the fusion PCR was
coligated with the SacI–BglII fragment of Sk (nt 651–4488) into the corre-
sponding SalI*/BglII restriction enzyme (RE) sites of plasmid GFP-a1S.
GFP-a1SkI-IIa. The HindIII–EcoRI fragment of Sk (nt 59 polylinker-
1007) and the EcoRI*-SphI A/Sk SOE fusion product (nt A1085–Sk1735)
with the A/Sk transition at position (nt A1461/Sk1297) were coligated into
the HindIII/SphI-cleaved polylinker of plasmid pSV-Sport1 (Life Tech-
nologies.). The SbfI–SphI fragment (nt 59 polylinker-Sk1735) of this inter-
mediate clone was coligated with the SphI–XhoI fragment of Sk (nt 1735–
2654) into the corresponding SbfI/XhoI RE sites of plasmid GFP-a1S.
GFP-a1SkII-IIIm. The EcoRI–BalI fragment of Sk (nt 1007–1973) was
coligated with the BalI–NdeI fragment (nt 1982–2296) from the muscle a1
subunit (M) of Musca domestica (Grabner et al., 1994) into plasmid pSP72
(Promega) using the internal NdeI site (plasmid nt 2379) and the EcoRI
site of the polylinker. The NdeI/EcoRI RE sites of pSP72 were also used
to coligate two cDNA fragments, the NdeI*/XhoI fragment that was PCR
generated from clone SkLC, a GFP-a1S with a cardiac (C) II-III loop (nt
C2716–Sk2654) (Grabner et al., 1999) plus the XhoI/BglII fragment of Sk
(nt 2654–4488). The NdeI* primer was designed to introduce downstream
of the NdeI* site additional Musca residues, A907G and S908T. In a sub-
sequent step fragments EcoRI–NdeI (nt Sk1007–M2297) and NdeI*–
BglII (C2716–Sk4488) were isolated from the pSP72 subclones and coli-
gated into the EcoRI/BglII-cleaved pSP72 vector. Finally, the SalI–EcoRI
fragment of Sk (nt 59 polylinker-1007) was coligated with the EcoRI–BglII
fragment (nt Sk1007–Sk4488) from the last pSP72 subclone into the SalI/
BglII sites of plasmid GFP-a1S.
GFP-a1SkIII-IVa. The III-IV loop of the A cDNA was inserted into the
corresponding Sk cDNA by a three-fragment SOE fusion PCR, thereby
generating the transitions Sk/A (nt Sk3195/A4561) and A/Sk (nt A4725/
Sk3355). The final PCR product was cleaved at its peripheral Sk XhoI/
BglII RE sites and the resulting fragment (nt 2654–4488) was ligated into
the corresponding XhoI/BglII sites of plasmid GFP-a1S.
GFP-a1Sa. The XhoI–SmaI fragment of Sk (nt 2654–4038) and the
SmaI–BglII Sk/A cDNA fusion fragment (nt Sk4038–A5891) with the Sk/
A transition (nt Sk4143/A5461) created by SOE PCR were coligated into
the XhoI/BglII RE sites of plasmid GFP-a1A (nt 1395/5891). Note that the
XhoI sites are not corresponding RE sites and were used for subcloning
only. Finally, the HindIII–XhoI fragment of Sk (nt 59 polylinker-2654)
was inserted into this HindIII/XhoI (nt 59 polylinker/A1395, Sk2654)
opened subclone to yield plasmid GFP-a1Sa.
GFP-a1As. The Xho–AccI fragment of A (nt 1395–4504) was coligated
with the A/Sk SOE fusion fragment AccI–BglII (nt A4504–Sk4488) carry-
ing its A/Sk transition at nt A5460/Sk4144, into the XhoI/BglII (nt 2654/
4488) cleaved plasmid GFP-a1S. Again, the A and Sk XhoI sites are not cor-
responding RE sites and were only used for subcloning. To yield GFP-a1As,
the SalI–EcoRI fragment from A (nt 59 polylinker-1567) was coligated with
the EcoRI–BglII fragment (nt A1567–Sk4488) after isolation from the sub-
clone into the SalI/BglII (nt 59 polylinker/4488) cleaved plasmid GFP-a1S.
GFP-a1Aas. The PCR generated BglII*–XbaI* fragment of Sk (nt 4566–
4991) was inserted into the corresponding BglII/XbaI RE sites of plasmid
GFP-a1A (nt 5891/39 polylinker). Upstream from the artificial XbaI* site of
the Sk fragment, two stop codons (nt 4984–4989) were introduced to termi-
nate the reading frame at residue T1661, which is close to the physiological
clipping site of the a1S carboxyl terminus (De Jongh et al., 1991).
GFP-a1Aas(1524-1591). The BglII*–XbaI* Sk/A cDNA fusion fragment
(nt Sk4566–A6347) with the Sk/A transition (nt Sk4773/A6118) generated
by SOE PCR was ligated into the corresponding BglII/XbaI RE sites of
plasmid GFP-a1A (nt 5891/39 polylinker). Again, two stop codons were in-
troduced upstream of the artificial XbaI* site of the A portion of the fusion
product (nt 6340–6345) to terminate the reading frame at residue G2113.
GFP-a1Aas(1592-clip). The BglII–XbaI* A/Sk SOE fusion fragment (nt
A5891–Sk4991) with the A/Sk transition at nt A6117/Sk4774 was ligatedFlucher et al. Ca21 Channel Triad Targeting Signal 469
into the corresponding BglII/XbaI RE sites of plasmid GFP-a1A (nt 5891/
39 polylinker).
GFP-a1A-clip. The BglII–XbaI* fragment of A (nt 5891–6347) was li-
gated into the corresponding BglII/XbaI RE sites of plasmid GFP-a1A (nt
5891/39  polylinker). Stop codons were introduced as in plasmid GFP-
a1Aas(1524–1591).
GFP-a1Aas(1607-clip). The BglII–XbaI* A/Sk SOE fusion fragment (nt
A5891–Sk4991) with the A/Sk transition at nt A6165/Sk4819 was ligated
into the corresponding BglII/XbaI RE sites of plasmid GFP-a1A (nt 5891/
39 polylinker).
All cDNA portions modified by PCR were checked for sequence integ-
rity by sequence analysis (sequencing facility of MWG Biotech).
GFP and Immunofluorescence Labeling
Differentiated GLT cultures were fixed and immunostained as previously
described (Flucher et al., 1994), using the monoclonal antibody 1A against
the DHPR a1S subunit at a final concentration of 1:1,000 (Morton and
Froehner, 1987), the affinity purified antibody #162 against the type 1
RyR at a dilution of 1:5,000 (Giannini et al., 1995), and a monoclonal or
an affinity purified anti–GFP antibody at a dilution of 1:2,000 and 1:4,000,
respectively (Molecular Probes, Inc.). Alexa- and fluorescein-conjugated
secondary antibodies were used with the anti–GFP antibodies so that the
antibody label and the intrinsic GFP signal were both recorded in the
green channel. Texas red–conjugated antibodies were used in double-
labeling experiments to achieve a wide separation of the excitation and
emission bands. Controls (for example, the omission of primary antibod-
ies and incubation with inappropriate antibodies) were routinely per-
formed. Images were recorded on an Axiophot microscope (Carl Zeiss,
Inc.) using a cooled CCD camera and Meta View image processing soft-
ware (Universal Imaging, Corp.).
Quantitative analysis of the labeling patterns was performed by system-
atically screening the coverslips for transfected myotubes using a 633 ob-
jective. The labeling pattern of positive myotubes with more than two nu-
clei were classified as either “clustered,” “ER/SR,” or “other” in the case
that the labeled compartment was not clearly identifiable. The counts
were obtained from several samples of at least three different experiments
for each condition.
Patch-Clamp and Fluorescent Ca21 Recording
Whole cell patch-clamp recordings were performed with an Axopatch
200A amplifier controlled by pClamp 8.0 software (Axon Instruments,
Inc.). The bath solution contained (mM): 10 CaCl2 or 3 CaCl2 plus 7
MgCl2, 145 tetraethylammonium chloride, and 10 HEPES (pH 7.4 with
TEA-OH). Patch pipettes had resistances of 2–4 MV when filled with 145
Cs-aspartate, 2 MgCl2, 10 HEPES, 0.1 Cs-EGTA, 2 Mg-ATP (pH 7.4 with
Cs-OH). Leak currents were digitally subtracted by a P/4 prepulse proto-
col. Recordings were low-pass Bessel filtered at 2 kHz and sampled at 5
kHz. Currents were determined with 200-ms depolarizing steps from a
holding potential of 280 mV to test potentials between 240 and 180 mV
in 10-mV increments. Test pulses were preceded by a 1-s prepulse to 230
mV to inactivate endogenous T-type Ca21 currents (Adams et al., 1990).
Action potential–induced Ca21 transients were recorded in cultures in-
cubated with 5 m M Fluo-4-AM plus 0.1% Pluronic F-127 (Molecular
Probes, Inc.) in HEPES and bicarbonate-buffered DME for 45 min at
room temperature, as previously described (Flucher et al., 1994; Powell et
al., 1996). Action potentials were elicited by passing 1-ms pulses of 30 V
across the 19-mm incubation chamber. 0.5 mM Cd21 and 0.1 mM La31
were added to block Ca21 influx and therefore allow discrimination be-
tween Ca21-induced Ca21 release and skeletal-type EC coupling. Applica-
tion of 6 mM caffeine proved the functionality of SR Ca21 release.
Results and Discussion
Reconstitution of Triad Targeting in Dysgenic Myotubes 
Transfected with the Skeletal Muscle Ca21
Channel a1S Subunit
Normal skeletal muscle in culture forms junctions between
the SR and t tubules (triads and diads) and between the
SR and the plasma membrane (peripheral couplings).
These types of junctions are equivalent in function in that
they support skeletal muscle type EC coupling, in molecu-
lar composition in that they contain RyRs in the SR and
DHPRs in t tubules and plasma membrane, and in struc-
ture in that the two types of Ca21 channels are organized
in characteristic arrays of feet and tetrads, respectively.
Therefore, we will henceforth use the terms “triad” and
“triad targeting” in a generic sense to include all these
types of junctions.
Dysgenic muscle lacks the a1S subunit of the L-type
Ca21 channel, but still forms regular junctions containing
RyRs (Powell et al., 1996). Transient transfection of myo-
tubes of the dysgenic cell line GLT with an expression
plasmid encoding a fusion protein of the GFP and the a1S
subunit (GFP-a1S) restores expression of the a1S subunit in
the triads, L-type Ca21 currents, and skeletal muscle EC
coupling (present study, and Grabner et al., 1998). Recon-
stitution of dysgenic myotubes with a1S is well established
and the properties observed here with the NH2-termi-
nal GFP-fusion protein are similar to those previously
reported with a COOH-terminal GFP-fusion protein
(Flucher et al., 2000) or to wild-type a1S expressed in dys-
genic myotubes (Tanabe et al., 1988).
The triad localization of GFP-a1S can be detected in dou-
ble immunofluorescence labeling experiments with antibod-
ies against the a1S subunit and against the RyR (Fig. 1, a and
Figure 1. Normal incorporation of heterologously expressed
GFP-a1S in t tubule/SR junctions of dysgenic myotubes. (a and b)
Double immunofluorescence labeling of a1S subunits (a) and
RyRs (b) shows that GFP-a1S is colocalized with RyRs in clusters
(examples indicated by arrows), presumably representing triad
junctions and peripheral couplings. A nontransfected myotube in
the same field (#) shows RyR clusters but no a1S labeling. (c and
d) Double staining of GFP-a1S with antibodies against a1S and
against GFP shows that the fusion protein can be localized using
either one of the antibodies. (e and f) As with anti–a1S (a), clus-
ters labeled with anti–GFP (e) are colocalized with RyR clusters
(examples indicated by arrows). In poorly differentiated myo-
tubes that lack RyR clusters (*), GFP-a1S accumulates in a reticu-
lar membrane system with densities in the perinuclear region,
presumably the ER/SR network. N, nuclei. Bar, 10 mm.The Journal of Cell Biology, Volume 151, 2000 470
b). Immunolabeling results in a punctate distribution pat-
tern of anti–a1S that is colocalized with similar clusters of
anti–RyR. This clustered distribution pattern is characteris-
tic of triad proteins in developing myotubes, and the coex-
istence of the t-tubule protein a1S with the SR protein, the
RyR, is indicative of their localization in junctions between
the two membrane systems (Flucher et al., 1994). Myotubes
not expressing GFP-a1S form RyR clusters (Fig. 1 b), which
have previously been shown to correspond to t tubule/SR
junctions by electron microscopy (Powell et al., 1996).
Double immunofluorescence labeling of GFP-a1S with
anti–GFP and anti–a1S (Fig. 1, c and d) or with anti–GFP
and anti–RyR (e and f) results in the same clustered distri-
bution pattern in equally large fractions of GFP-a1S–
expressing myotubes (57 and 58%, respectively). There-
fore, we continued using anti–GFP for the immunolocalization
of GFP-a1 constructs, because it recognizes both GFP-a1S
and GFP-a1A, allowing the direct comparison of the label-
ing patterns of all chimeras used in this study. Fig. 1 e also
shows a myotube in which the GFP-a1S is expressed but its
labeling pattern is not clustered. Instead it is distributed
throughout a tubular membrane system that is very dense
in the perinuclear region and has previously been identi-
fied as the ER/SR (Powell et al., 1996; Flucher et al.,
2000). ER/SR distribution of heterologously expressed a1
subunits can be observed with all constructs and occurs
preferentially in poorly differentiated cells; i.e., myotubes
in which triads are not formed. The myotube shown in Fig.
1, e and f, for example, lacks RyR clusters, indicating that
triad junctions, and thus the target for GFP-a1S, was miss-
ing and therefore GFP-a1S was retained in the biosynthetic
apparatus. However, in addition to myotubes lacking the
target for the a1 subunit, retention in the ER/SR system
can also be observed in normally differentiated myotubes
if they are transfected with a1 constructs lacking the triad
targeting signal (see below).
Differential Targeting of the Skeletal and the Neuronal 
Ca21 Channel a1 Subunits Expressed in
Dysgenic Myotubes
Fig. 2 shows a direct comparison of the labeling patterns of
the skeletal muscle GFP-a1S and the neuronal GFP-a1A ex-
pressed in dysgenic myotubes. Whereas double immunola-
beling with anti–GFP and anti–RyR reveals the colocaliza-
tion of GFP-a1S and RyR in the junctions (Fig. 2, a–c),
GFP-a1A is localized exclusively in the ER/SR network (d),
Figure 2. Differential targeting of GFP-a1S and GFP-a1A in transiently transfected dysgenic myotubes. Double immunofluorescence la-
beling of the skeletal GFP-a1S and the neuronal GFP-a1A (using anti–GFP for both) and of the RyR shows that only GFP-a1S is colocal-
ized with RyR clusters (a and b; examples indicated by arrows). GFP-a1A is not colocalized with RyR clusters (d and e), but is retained in
a reticular cytoplasmic membrane system, the ER/SR (d). (c and f) The differential subcellular distribution of GFP-a1S and GFP-a1A is
highlighted in a color overlay of the images of a and b, and d and e, respectively (insets at twofold magnification). Colocalization of GFP-
a1S (green) with RyRs (red) results in yellow clusters. In contrast, separate green GFP-a1A and red RyR labeling indicates the lack of
colocalization of GFP-a1A and RyRs. Bar, 10 mm.Flucher et al. Ca21 Channel Triad Targeting Signal 471
even though the presence of RyR clusters (e) indicates the
normal differentiation of junctions. The merged color im-
ages of GFP-a1 in green and RyR in red further empha-
sizes the differential targeting of the skeletal and neuronal
channels. Here, colocalization of GFP-a1S with RyR shows
up as yellow clusters (c), whereas the distinct localization
of GFP-a1A in the ER/SR and RyR in clusters is seen as
separate green and red label, respectively (f). Quantifica-
tion of the labeling patterns in at least six independent ex-
periments showed that, while the overall expression of
both constructs was the same, clusters were observed in
58% (n 5 967) of the myotubes transfected with GFP-a1S,
but never in myotubes expressing GFP-a1A (n 5 418).
Thus, GFP-a1A fails to be incorporated into triad junctions.
To exclude the possibility that the absence of GFP-a1A
resulted from improper folding or lack of plasma mem-
brane incorporation of the GFP-a1A construct rather than
lack of a triad targeting signal, we performed patch-clamp
recordings of myotubes expressing this construct. Even
though a plasma membrane stain was not detected with
immunocytochemistry in GFP-a1A–transfected myotubes,
the whole-cell recordings showed large Ca21 currents with
the macroscopic properties of class-A Ca21 channels ex-
pressed in heterologous mammalian expression systems
(example shown in Fig. 6, below) (Adams et al., 1994).
Thus, GFP-a1A expressed in dysgenic myotubes formed
functional channels in the cell membrane. But instead of
becoming locally concentrated in the triads, GFP-a1A was
distributed diffusely in the plasma membrane at densities
below detectability with immunocytochemistry.
Recordings of cytoplasmic Ca21 transients in response
to electrical field stimulation showed that GFP-a1S regu-
larly restored skeletal muscle EC coupling in dysgenic
myotubes (see Fig. 7, and Powell et al., 1996; Flucher et al.,
2000). In contrast, restoration of EC coupling by GFP-a1A
was only rarely observed (see below). Thus, both the skel-
etal muscle GFP-a1S isoform and the neuronal GFP-a1A
isoform were functionally expressed in dysgenic myotubes,
but only GFP-a1S was targeted into the triad junctions and
efficiently restored EC coupling. The differential distribu-
tion of GFP-a1S and GFP-a1A as well as their functional
differences are in general agreement with observations
from a previous study comparing the expression of GFP-
a1S, GFP-a1A, and a cardiac GFP-a1C construct in primary
cultured dysgenic myotubes (Grabner et al., 1998). In that
study, GFP-a1A differed from the muscle isoforms in that
its distribution patterns were restricted to near the injec-
tion site and that only GFP-a1A failed to respond in a con-
traction assay. Together, these data support our hypothe-
sis that the skeletal muscle a1S contains a signal for its
targeting and selective incorporation into triads, but that
such a triad targeting signal is missing from the neuronal
a1A subunit isoform.
Localization of the Triad Targeting Site to the COOH 
Terminus of the a1S Subunit
With a properly targeted GFP-a1S and a nontargeted GFP-
a1A in our hands, we decided to start screening for the loca-
tion of the targeting signal by replacing the prominent cy-
toplasmic portions of GFP-a1S with the corresponding
sequences of a1A. GFP-a1S/a1A chimeras were generated
with the following portions of a1A (Fig. 3): the NH2 terminus
(GFP-a1SkNa), the cytoplasmic loop connecting repeats I
and II (GFP-a1SkI-IIa) or that connecting repeats III and
IV (GFP-a1SkIII-IVa), and the COOH terminus (GFP-
a1Sa). Because the II-III loop of a1A is more than three
times the size of that of a1S, we were concerned that it might
impede appropriate incorporation of a chimera, not be-
cause of lacking a triad targeting signal, but because of ster-
ical hindrance. Instead, the II-III loop of the house fly (M.
domestica) a1 subunit (Grabner et al., 1994) was used for
constructing a II-III chimera (GFP-a1SkII-IIIm). Its II-III
loop has similar size as that of the rabbit skeletal muscle a1S
but shows very little sequence homology to a1S and, like
a1A, the Musca a1 subunit failed to be targeted into the junc-
tions. Double immunolabeling with anti–GFP and anti–
RyR and subsequent analysis of the targeting properties
revealed that all of these chimeras with the exception of
GFP-a1Sa were clustered together with the RyR. The clus-
tering efficiencies were between 50 and 65% (n 5 200) for
each construct, which was similar to that of GFP-a1S (Fig.
3). Thus, neither the NH2 terminus nor any of the major cy-
toplasmic loops of a1S are essential for triad targeting.
The I-II loop contains the interaction domain for the b
subunit (Pragnell et al., 1994). Association of the b subunit
Figure 3. Screening for the molecular location of the triad target-
ing signal in a1S/a1A chimeras. Schematic representation of the mem-
brane topology of the a1 subunit isoforms and chimeras with a1S se-
quences in gray and a1A sequences in black. Large cytoplasmic
portions of a1S were systematically replaced by the corresponding
sequences of a1A (or in the case of GFP-a1SkII-IIIm of the Musca a1
sequence). The bar graph at the right shows the percentage of trans-
fected myotubes in which the expressed a1 subunit isoform/chimera
achieved a clustered distribution indicative of correct triad targeting.The Journal of Cell Biology, Volume 151, 2000 472
with this loop has been implicated in an important early
step in membrane insertion of Ca21 channels (Bichet et al.,
2000). The I-II loop at least of a1A seems to contain an ER
retention signal that is blocked upon association with b to
release the complex from the ER. Since the b interaction
domain in the I-II loop is shared by all known a1 subunits
and a b subunit is endogenously expressed in dysgenic
myotubes, a negative effect on triad targeting due to this
mechanism was not to be expected with the GFP-a1SkI-
IIa chimera. The II-III loop of a1S contains the sequence
important for the interaction with the RyR. It specifies the
tissue-specific mode of EC coupling (Tanabe et al., 1990a)
and the amplification of Ca21 currents by association with
the skeletal type 1 RyR (Nakai et al., 1996; Grabner et al.,
1999). Therefore, it is quite remarkable that replacement
of the a1S II-III loop by a loop as different as that of
Musca’s  a1 subunit had no adverse effect on triad targeting
of chimera GFP-a1SkII-IIIm. On the other hand, the find-
ing that the molecular domain responsible for DHPR-
RyR interactions is not essential for triad targeting is con-
sistent with the observations showing that, in the RyR1
knock-out mouse, a1S clusters in the junctions despite the
lack of RyR1 (Takekura et al., 1995).
Replacing the COOH terminus of GFP-a1S with that of
a1A (GFP-a1Sa) disrupted triad targeting (Fig. 4, a–c). Sim-
ilar to the distribution pattern described above for GFP-
a1A, GFP-a1Sa was found in the ER/SR system, but never
in clusters together with the RyR. Ca21 currents in GFP-
a1Sa-transfected cells were very small and frequently below
detectability. This is not surprising for skeletal Ca21 chan-
nels not localized in the triad junctions. Nakai et al. (1996)
and Grabner et al. (1999) have shown that skeletal muscle
a1S requires the specific interaction with type 1 RyR in the
junctions for the expression of normal current densities.
Both the absence of RyR1 in dyspedic myotubes and the
interruption of the interaction between a1S and the RyR re-
sulted in a considerable attenuation of skeletal Ca21 cur-
rents. Similarly, it is to be expected that in addition to de-
creased membrane insertion, the failure of triad targeting
of GFP-a1Sa and the associated lack of interactions with
the RyR would result in the attenuation of Ca21 currents.
The failure of triad targeting in the GFP-a1Sa chimera
suggests that the triad targeting signal may be contained
within the COOH terminus of a1S. To verify this interpre-
tation, the corresponding reverse chimera, GFP-a1A with
the COOH terminus of a1S (GFP-a1As) was constructed.
Figure 4. Exchange of the targeting properties between GFP-a1S and GFP-a1A by swapping their COOH-terminal tails. (a and b) Ex-
pression of an a1S chimera with the COOH terminus of a1A (GFP-a1Sa) in dysgenic myotubes results in a loss of triad targeting; instead,
GFP-a1Sa was consistently localized in the ER/SR system. (d and e) The converse chimera, GFP-a1As, has gained the ability to become
coclustered with RyRs in the junctions (examples indicated by arrows). (c and f) The color overlays show the lack of colocalization of
GFP-a1Sa and RyR clusters, but a high degree of colocalization of clustered GFP-a1As and RyRs (insets at twofold magnification). Red
and green clusters in f are mostly due to differences in labeling intensities and not due to differential distribution of GFP-a1As and RyR
(compare d and e). N, nuclei. Bar, 10 mm.Flucher et al. Ca21 Channel Triad Targeting Signal 473
When expressed in dysgenic myotubes, GFP-a1As was
found coclustered with the RyR (Fig. 4, d–f). The effi-
ciency of clustering was somewhat reduced compared with
wild-type GFP-a1S (28% of 1,479 transfected myotubes
from eight separate experiments; Fig. 3); however, it was
clear that by replacing its COOH terminus with that of a1S,
this otherwise class-A channel gained the ability to be tar-
geted into the triad junctions. Ca21 currents with proper-
ties similar to those of GFP-a1A were expressed (see Fig. 6
b), indicating that this channel chimera was functional.
Since swapping the COOH termini of a1S and a1A con-
ferred triad targeting properties to the neuronal isoform
(GFP-a1As) and disrupted triad targeting in the skeletal
muscle Ca21 channel isoform (GFP-a1Sa), it was evident
that the signal responsible for this specific localization
must be contained in the COOH terminus of a1S.
Localization of the Triad Targeting Signal within the 
COOH Terminus of a1S
The skeletal muscle a1S subunit isolated from muscle prep-
arations exists in two size forms, the minor fraction corre-
sponding to the full-length a1S sequence and the major
fraction corresponding to a COOH-terminally truncated
a1S, lacking the sequences distal to approximately residue
1661 (De Jongh et al., 1991). Although truncation occurs
after incorporation of a1S into the junctions (Flucher et al.,
2000), the truncated form by itself is sufficient to restore
skeletal muscle EC coupling in dysgenic myotubes (Beam
et al., 1992), suggesting that it is correctly inserted into the
junctions. Therefore, it seemed unlikely that the triad tar-
geting signal resides in the part of the COOH terminus
distal to the putative clipping site. Sequence comparison of
different a1 subunit isoforms showed that the first 140 resi-
dues of the COOH terminus are highly homologous, fol-
lowed by a stretch of similar length with much lower se-
quence homology. Thus, we concentrated our search for
the triad targeting signal on the stretch in between the
highly homologous region and the putative clipping site of
a1S. We created one chimera (GFP-a1Aas) with the skele-
tal sequence 1524–1661 substituted for the corresponding
region of a1A, and two daughter chimeras, each containing
one half of that region from a1S (see Fig. 6 a). GFP-
a1Aas(1524-1591), which contains the proximal half of this re-
gion from a1S (1524–1591) and the distal half from a1A,
ends at an arbitrary site of a1A corresponding to the loca-
tion of the clipping site in a1S, because a1A does not con-
Figure 5. Localization of the triad targeting signal within the COOH-terminal tail of a1S. (a–c) Chimera GFP-a1Aas consisting of the
body plus the first 145 COOH-terminal residues of a1A and the remaining COOH terminus of a1S ending at the putative clipping site at
position 1661 is readily targeted into the junctions when expressed in dysgenic myotubes (example indicated by arrows). (d–f) Chimera
GFP-a1Aas(1524-1591) containing only the proximal half of this COOH-terminal a1S sequence fails to be targeted into the junctions. (g–i)
However, chimera GFP-a1Aas(1592-clip) containing the distal half of this COOH-terminal a1S sequence is efficiently targeted into junc-
tions of t tubules and plasma membrane with the SR (example indicated by arrows). (c, f, and i) Color overlays of images shown above;
insets at twofold magnification. N, nuclei. Bar, 10 mm.The Journal of Cell Biology, Volume 151, 2000 474
tain this putative clipping site itself. GFP-a1Aas(1592-clip) is
neuronal up to residue 2039 of a1A, with the distal part of
a1S, from residue 1592 to the putative clipping site (1661).
Fig. 5, a–c, shows that GFP-a1Aas was correctly targeted
into the triad junctions. 38% (n 5 1,602) of the transfected
myotubes showed a clustered distribution of GFP-a1Aas
colocalized with RyR immunolabel. This confirmed that
the region beyond residue 1661, which can be subject to
truncation, is not necessary for triad targeting. Rather, the
triad targeting signal is contained in the sequence between
residues 1524 and 1661 of a1S. Within this region, the prox-
imal half did not confer triad targeting properties to a1A.
Not a single myotube out of 887 GFP-a1Aas(1524-1591)–
transfected myotubes showed a clustered distribution pat-
tern of this a1 chimera; instead, GFP-a1Aas(1524-1591) was
regularly found in the ER/SR (Fig. 5, d–f). In contrast, its
sister chimera GFP-a1Aas(1592-clip) was efficiently targeted
to the junctions (Fig. 5, g–i). 41% (n 5 1,076) of the trans-
fected myotubes showed a clustered distribution of GFP-
a1Aas(1592-clip) colocalized with the RyR, indicating that this
70 amino acid sequence contains the triad targeting signal.
To further restrict the region containing the triad targeting
signal, one more chimera was created with only the last 55
residues proximal to the putative clipping site from a1S
(GFP-a1Aas(1607-clip)). This construct was also found in
clusters in 47% (n 5 603) of the transfected myotubes (Fig.
6 a; immunofluorescence image not shown), demonstrat-
ing that the 55 amino acid segment between residues 1607
Figure 6. Targeting properties and current properties of wild-type a1 subunit isoforms and COOH-terminal chimeras. (a) Isoform se-
quence composition of COOH termini in the studied chimeras, with sequences of a1S in gray and a1A in black. Bar graph indicates the
percentages of transfected myotubes showing triad targeting in immunofluorescence analysis. Alignment of the 55 a1S amino acids con-
taining the targeting signal with the corresponding sequences of a1C and a1A. (b) Representative current traces recorded from dysgenic
myotubes transfected with wild-type GFP-a1S (in 10 mM Ca21), with GFP-a1A or with the targeted chimera GFP-a1As (both in 3 mM
Ca21). Currents from GFP-a1Sa (in 10 mM Ca21) were too small for systematic analysis; see frequency distribution of current densities.
(c) Representative current trace of the targeted chimera GFP-a1Aas(1592-clip) and comparison of peak current densities recorded from
GFP-a1A, GFP-a1Aas(1592-clip), and GFP-a1Aas(1524-1591). Substituting COOH-terminal a1A sequence with the skeletal sequence 1592–1661
results in a twofold increase of current density compared with GFP-a1A, whereas substituting for skeletal sequence 1524–1591 reduces
the current densities to near the detection level and could be analyzed only after increasing the Ca21 concentration to 10 mM (n 5 7–17).
Table I. Restoration of Action Potential-induced Ca21 Transients in Dysgenic Myotubes Expressing Different a1 Subunit Isoforms 
and the Targeted Chimera GFP-a1Aas(1592-clip)
Construct
Cultures showing action potential-
induced Ca21 transients* Responsive myotubes per dish‡
%n n
GFP-a1S 95 22 26.6 6 22.2 14
GFP-a1C 100 22 27.9 6 23.5 22
GFP-a1A 22 23 0.2 6 0.4 22
GFP-a1Aas(1592-clip) 60 43 1.8 6 2.4 40
*Percentages of culture dishes with one or more responsive myotubes of number of dishes (n) tested.
‡Standard deviation of the mean of n dishes tested.Flucher et al. Ca21 Channel Triad Targeting Signal 475
and 1661 of the skeletal muscle a1S is sufficient to confer
triad targeting properties to the neuronal a1A subunit.
Comparing this sequence of a1S with the corresponding
sequences of the cardiac a1C, which is also targeted to tri-
ads (Grabner et al., 1998), and with that of the nontar-
geted a1A reveals surprisingly few residues that are con-
served between a1S and a1C but distinct from a1A (Fig. 6 a).
However, replacing individual of these residues with ala-
nin did so far not result in a loss of targeting properties
(data not shown). Either a targeting motif within this 55
amino acid stretch of a1S is made up of more than those
residues conserved between a1S and a1C, or the signal that
is contained in this sequence stretch of a1S is located out-
side the corresponding region of a1C (see below). To dis-
tinguish between these possibilities, the corresponding tar-
geting signal in a1C and other a1 isoforms needs to be
localized and extensive single and combinatorial amino
acid mapping needs to be performed.
The importance of COOH-terminal sequences in target-
ing and immobilization in specialized neuronal membrane
domains has been demonstrated for ligand- and voltage-
gated ion channels (Sheng and Pak, 1999; Lim et al., 2000).
To our knowledge, the sequence between 1607 and 1661 of
a1S contains only one known consensus protein binding
site. The sequence SPV in position 1640–1642 corresponds
to the PDZ-binding motif S/TXV; however, it is not posi-
tioned at the very COOH terminus as is the case in the
majority of reported PDZ-binding proteins (Sheng, 1996).
Using a yeast–two-hybrid assay, Proenza et al. (2000) re-
cently observed that this motif is part of a highly reactive
region in the COOH terminus of a1S and that substitution
of the valine within this motif by aspartate abolished the
high reactivity. This makes the PDZ-binding motif within
the region demonstrated to contain the triad targeting sig-
nal in the present study a good candidate for protein–pro-
tein interactions that may contribute to triad targeting.
However, the corresponding sequence in a1C lacks the crit-
ical valine of this motif. Thus, if binding to PDZ proteins
were the mechanism of triad targeting, other PDZ-binding
motifs located elsewhere in the channel had to be respon-
sible for the same function in the cardiac isoform. Two
such motifs exist in the COOH terminus of a1C, however,
immediately distally to the putative clipping site. Other ev-
idence for the importance of the COOH terminus in mem-
brane targeting comes from heterologous expression of
the cardiac a1C in tsA201 cells (Gao et al., 2000). However,
the region identified in that study to be important for func-
tional membrane expression of a1C is in the proximal,
highly homologous part of the COOH terminus, ending 69
amino acids upstream of the region corresponding to the
triad targeting signal identified in our study using a gain-
of-function approach. Assuming that the loss of function
in response to COOH-terminal truncations and deletions
arose from specific effects on the targeting process rather
than from nonspecific damage to the expressed channel,
this domain is most likely not involved in the highly spe-
cific insertion of the channel into triad junctions, but may
be important for a more general aspect like the export
from the ER or membrane incorporation. Our present re-
sults do not exclude the possible contribution of other sig-
nals, shared by a1S and a1A, to the complex process that
culminates in triad targeting.
Effects of Triad Targeting of GFP-a1Aas(1592-clip) on 
Ca21 Currents and EC Coupling
Comparison of the current properties of GFP-a1A and
GFP-a1Aas(1524-1591), both of which are not targeted into
the triad, with that of the targeted GFP-a1Aas(1592-clip) pro-
vides additional evidence for the existence of distinct
mechanisms for membrane and triad targeting (Fig. 6, b
and c). Compared with GFP-a1A, GFP-a1Aas(1524-1591) ex-
hibited strongly reduced current densities, even though the
immunolabeling experiments gave no indication that the
transfection efficiency or the amount of protein expressed
had been decreased. It was necessary to increase the con-
centration of the charge carrier from 3 to 10 mM Ca21
(Fig. 6 c) to show that this chimera did in fact express func-
tional channels in the membrane; however, at strongly re-
duced levels. This suggested that in this chimera a distinct
Figure 7. Restoration of EC coupling by targeted and nontar-
geted Ca21 channel isoforms. Action potential–induced Ca21
transients were recorded in transfected dysgenic myotubes loaded
with the fluorescent Ca21 indicator Fluo4-AM, using tetanic elec-
trical stimulation (left, 20 Hz, 2 s, bracket) or low frequency stim-
ulation (center, 0.3–0.5 Hz as marked). 0.5 mM Cd21/0.1 mM
La31 (gray bar) was applied to block the Ca21 influx during the
low-frequency stimulation protocol. Ca21 release from the SR
could be triggered by the application of 6 mM caffeine (gray bar)
to the bath after current block. Myotubes transfected with the
skeletal GFP-a1S responded to electrical stimulation with Ca21
transients independently of Ca21 influx. The cardiac GFP-a1C
also reconstituted EC coupling in dysgenic myotubes; however,
Ca21 transients stopped when the Ca21 influx was blocked. Car-
diac-type Ca21 transients in response to electrical stimulation
were rarely observed in dysgenic myotubes transfected with GFP-
a1A (see Table I) and about nine times more often with the tar-
geted GFP-a1Aas(1592-clip). Example traces for each construct were
recorded from the same myotubes in sequential order.The Journal of Cell Biology, Volume 151, 2000 476
signal important for membrane expression of a1A had been
abolished, but that this loss had not been compensated by
the addition of the skeletal muscle triad targeting signal.
To find out whether this putative membrane insertion sig-
nal of a1A resides in the region replaced by the skeletal se-
quence (1524–1591) or whether it is contained in the distal
portion of the COOH terminus that had been truncated in
this chimera, we generated a truncated GFP-a1A and ex-
pressed it in the dysgenic myotubes (data not shown). Cur-
rent expression of this GFP-a1A-clip was also low, suggest-
ing that the distal COOH terminus of a1A contains a
separate signal that is important for its efficient membrane
expression, but is not sufficient for triad targeting.
Considering the fact that our final triad-targeting chime-
ras lack this a1A membrane-targeting signal, it is even more
astonishing that the skeletal residues 1592–1661 not only
fully compensated the loss of current expression caused by
the truncation of a1A, but that current densities of the tar-
geted GFP-a1Aas(1592-clip) were increased by approximately
twofold over those of the wild-type a1A (Fig. 6 c). Among
several possible causes for this effect, an increase in current
density accompanying triad targeting is consistent with a
model by which the specific incorporation into the triadic
complex stabilizes the channel in the membrane, thus lead-
ing to an increased total number of functional channels.
Finally, to the question of how the localization of a Ca21
channel in skeletal muscle affects EC coupling. The two
muscle isoforms, a1S and a1C, which are both targeted into
triads, have repeatedly been shown to rescue EC coupling
in dysgenic myotubes (Tanabe et al., 1988 and 1990b;
Grabner et al., 1998; Neuhuber et al., 1998b; Flucher et al.,
2000). However, the mechanism by which the skeletal
muscle  a1S and the cardiac a1C activate SR Ca21 release in
dysgenic myotubes differs. In a1S, it functions indepen-
dently of Ca21 influx, whereas a1C does require Ca21 influx
for the activation of EC coupling. In Fig. 7, we show that
dysgenic myotubes transfected with GFP-a1S or GFP-a1C
respond to electrical stimulation with strong Ca21 tran-
sients, which have previously been described as action po-
tential–induced Ca21 transients based on their all-or-none
characteristics (Flucher et al., 1994; Powell et al., 1996).
With GFP-a1S, these Ca21 transients continued after
blocking the Ca21 currents by the addition of Cd21/La31 to
the bath solution, whereas with GFP-a1C the Ca21 tran-
sients ceased, confirming that this SR Ca21 release was
Ca21-induced. Caffeine induced strong Ca21 transients
even after the Cd21/La31 block, indicating that the cessa-
tion of Ca21 transients was not due to depletion of the SR
Ca21 stores or damage to the release mechanism.
Previous attempts to rescue EC coupling in dysgenic
myotubes by expressing the neuronal a1A failed to display
(Grabner et al., 1998), or only very rarely displayed,
evoked contractions (Adams et al., 1994), despite the fact
that a1A expressed sizable Ca21 currents. Using a more di-
rect method to monitor SR Ca21 release with the fluores-
cent Ca21 indicator fluo-4, we did observe rare action po-
tential–induced Ca21 transients in GFP-a1A–transfected
myotubes (Table I and Fig. 7). While .25 responsive myo-
tubes were found in almost all of GFP-a1S– and GFP-a1C–
transfected cultures, on average only every fifth culture
transfected with GFP-a1A contained one or two responsive
myotubes. The degree of restoration of EC coupling in-
creased significantly (P 5 0.002) when the class-A channel
was targeted into the triad. In myotubes transfected with
GFP-a1Aas(1592-clip), action potential–induced Ca21 tran-
sients were observed in 60% of the cultures (Table I). As
expected, these Ca21 transients could be blocked with
Cd21/La31, indicating that the mechanism by which GFP-
a1Aas(1592-clip) restored EC coupling was Ca21-induced
Ca21 release (Fig. 7).
The enhanced restoration of EC coupling by the targeting
of a class-A channel into the triads shows the importance of
the correct localization of the Ca21 channel in close proxim-
ity to the SR Ca21 release channel. Apparently, the large
Ca21 influx through a1A distributed throughout the plasma
membrane was not sufficient to induce Ca21-induced Ca21
release except in a few myotubes. However, concentrating
the Ca21 current to the restricted spaces of the triadic com-
partments strongly improved the chance of reaching the
threshold for Ca21-induced Ca21 release. This interpreta-
tion is consistent with other cellular processes where the
close proximity of a Ca21 source and a Ca21 target is re-
quired for normal function (e.g., the association of the RyR
and the Ca21-activated potassium channel in smooth muscle
cells; Jaggar et al., 2000) and highlights the importance of
specific targeting mechanisms for Ca21 channels.
The more we learn about Ca21 channels in their native
environments, the more it appears to be the rule rather
than the exception that they are specifically localized in
functional domains. The signal contained in the 55 amino
acid sequence of the COOH terminus of a1S is the first de-
scription of a targeting signal of a voltage-gated Ca21
channel for a specific membrane domain. It may share its
anchoring mechanism with other ion channels that have
been shown to interact with proteins containing PDZ do-
mains, but for which the importance of this protein–pro-
tein interaction in the targeting process has yet to be
shown. The complex passage of the skeletal muscle Ca21
channel from the biosynthetic apparatus into the triad
junction involves multiple steps. At the beginning of the
journey, the interaction of the b subunit with the I-II loop
and with the COOH terminus seems to play an important
role in the export of the channel from the ER and for its
functional expression in the plasma membrane. At the end
of the journey, the specific interaction with the RyR deter-
mines the tetradic organization of the a1S subunit that
structurally sets it apart from the cardiac a1C. But between
these two events occurs the essential targeting of the Ca21
channel into the junctional domain of the triad, and the
signal contained within residues 1607–1661 of the skeletal
muscle a1S subunit is necessary and sufficient to confer this
targeting property to a neuronal a1 subunit.
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